Results 131 to 140 of about 15,824 (192)

Ceftazidime-avibactam for multidrug and pandrug-resistant gram-negative infections in critically Ill children: a single-center pediatric ıntensive care experience. [PDF]

Eur J Pediatr
Havan M, Arga G, Bülbül YE, Özerdem B, Eyduran E, Aslan AD, Penezoğlu N, İnceli HB, Öcal D, Özdemir H, Çiftci E, Kendirli T.   +11 more
europepmc   +1 more source

UK Antimicrobial Registry: Virtual Registry-an innovative surveillance approach for monitoring the real-world use and effectiveness of newly licensed antimicrobials in Scotland. [PDF]

JAC Antimicrob Resist
Goswami C, Turgal E, Mueller T, Bennie M, Parr R, Jones GT, Seaton RA, Jenkins D, Baltas I, Sneddon J, Sandoe JAT, Garraghan F, Brown NM, Macfarlane GJ, Kurdi A.   +14 more
europepmc   +1 more source

Pseudomonas aeruginosa sequence type 357 with VEB extended-spectrum β-lactamases in the UK: relatedness and resistance [PDF]

, 2018
Greenwood, Beckie, Hill, Robert, Hopkins, Katie L, Ivanov, Zdravko, Livermore, David M, Meunier, Danièle, Pike, Rachel, Turton, Jane F, Woodford, Neil   +8 more
core   +1 more source

Combination of Ceftazidime-Avibactam and Meropenem for the Treatment of Pneumonia and Bloodstream Infections Caused by Pan-Drug Resistant <i>Pseudomonas aeruginosa</i> ST244: A Case Report. [PDF]

Infect Drug Resist
Kang Y, Kang S, Cui J.
europepmc   +1 more source

Combination of Ceftazidime-Avibactam and Aztreonam Effectively Treated Post-Cardiac Surgery Pneumonia Caused by Hypervirulent KPC- and NDM-Producing <i>Klebsiella pneumoniae</i>: A Case Report. [PDF]

Infect Drug Resist
Wei Q, Cong R, Shen C, Chen C, Cao Z, Ren C, Liu T.   +6 more
europepmc   +1 more source

<i>In vitro</i> activity of cefepime/zidebactam against <i>Klebsiella pneumoniae</i> carrying <i>bla</i> _KPC variants conferring resistance to ceftazidime/avibactam. [PDF]

JAC Antimicrob Resist
Tascini C, Marshall SH, Bonomo RA, Gaibani P.   +3 more
europepmc   +1 more source

Comparative analysis of the effects of aztreonam combined with four β-lactamase inhibitors against carbapenem-resistant <i>Enterobacterales</i>. [PDF]

Microbiol Spectr
Meng Q, Xu C, Li W, Shen K, Huang X, Fu X, Zhou L, Chen Y, Hu F, Wang H.   +9 more
europepmc   +1 more source

A genomics-informed mechanism-based pharmacokinetic/pharmacodynamic model of cefiderocol and ceftazidime/avibactam against carbapenem-resistant <i>Achromobacter xylosoxidans</i>. [PDF]

Antimicrob Agents Chemother
Arun B, Sharma R, Vallé Q, Bui NM, Furtado N, Ramirez MS, Rao G.   +6 more
europepmc   +1 more source

High-dose aztreonam potentiates the combined antimicrobial activity of ceftazidime-avibactam against extensively drug-resistant New Delhi metallo-β-lactamase positive <i>Pseudomonas aeruginosa</i> in severe pneumonia treatment: the first global case report. [PDF]

Front Cell Infect Microbiol
Liu Y, Mo C, Li M.
europepmc   +1 more source

Ceftazidime-Avibactam-Induced Neurotoxicity Manifesting as Seizure in an Older Adult: A Case Report. [PDF]

Infect Drug Resist
Li Z, Li C, Zhao P, Han Y, Lu N.
europepmc   +1 more source